Atox Bio
Retail · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Park Forty Plz Ste 210, Durham, Nor...Phone Number
(919) 439-3400Website
www.atoxbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Atox Bio
AtoxBio specializes in providing high-quality human growth hormone (HGH) therapy products for both children and adults seeking to enhance their overall wellness. The company offers a range of verified injectable HGH treatments at competitive prices, ensuring client satisfaction without compromising on safety or effectiveness. Targeting fitness enthusiasts, athletes, and individuals looking to improve their health, AtoxBio emphasizes trust and transparency in its operations. With a commitment to quality, AtoxBio stands out in the market by offering reputable HGH brands and personalized support for customers.Explore more
Atox Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Atox Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Atox Bio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Atox Bio
Click to see if Atox Bio had a recent Job posting/layoffs
Check if Atox Bio has recently received funding, and reach out quickly before it becomes old news!
Atox Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Atox Bio is spiking on competitors!
Product Launch: Get notified when Atox Bio launches new products
Funding: Get notified immidiatlly once Atox Bio has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Atox Bio
Compare insights from companies similar to Atox Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Atox Bio is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Atox Bio is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Atox Bio.
Atox Bio financials insights
Gather financial insights about Atox Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$3.3M
2014
Series E
$23M
2017
Series F
$30M
Atox Bio Tech Stack
A closer look at the technologies used by Atox Bio
See more technologies
Atox Bio News & Media
Atox Bio Announces a Positive Effect of Reltecimod on Resolution of Organ Dysfunction in Phase 3 ACCUTE Trial for Patients with Necrotizing Soft Tissue Infection (“Flesh Eating Disease”)
- After Discussions with FDA, NDA Submission Planned for 3Q 2020 under Accelerated Approval Pathway -Atox Bio's Reltecimod Shows Effectiveness in Flesh-Eating Bacterial Infections
Reltecimod is a synthetic peptide antagonist of both superantigen exotoxins and the CD28 T-cell costimulatory receptor.Atox Bio Announces Exercise by BARDA of Next Option Period to Support Continued Development of Reltecimod for NSTI
DURHAM, North Carolina and NESS ZIONA, Israel, June 18, 2019 /PRNewswire/ -- Atox Bio, a late stage clinical company developing immunotherapies for critically ill patients, today announced the Biomedical Advanced Research and Development Authority (BARDA) has exercised the next option on...Atox Bio Announces Appointment of Robert Greif as Chief Commercial Officer
CHAPEL HILL, North Carolina and NESS ZIONA, Israel, Feb. 14, 2019 /PRNewswire/ -- Atox Bio, a clinical stage company developing novel therapies for critically ill patients, today announced the appointment of Robert Greif as Chief Commercial Officer. In this newly created position, Robert...
Read more news
Top Retail Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Atox Bio
Sign Up For FreeTo access detailed company insights
AtoxBio specializes in providing high-quality human growth hormone (HGH) therapy products for both children and adults seeking to enhance their overall wellness. The company offers a range of verified injectable HGH treatments at competitive prices, ensuring client satisfaction without compromising on safety or effectiveness. Targeting fitness enth... Read More
